Lunate Holding Rsc Ltd

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0002009522

Type: FundHoldings: 4Value: $210.9MLatest: 2024Q4

Lunate Holding RSC Ltd is an institutional investment manager that filed its latest Form 13F for 2024Q4, reporting 4 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RVMD",
  "LINE",
  "BIRK",
  "NMRA"
]

Filing Details

13F-HR • 2024-12-31

SEC FilingSEC DataHachi Filing

Report Date: 2024-12-31
Filing Date: 2025-02-14
Total Holdings: 4
Total Value: 210946304
Accession Number: 0001011438-25-000154
Form Type: 13F-HR
CIK: lunate-holding-rsc
Manager Name: Lunate-Holding-Rsc

Data Enrichment

100% identified

4 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

4 positions • $210.9M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Revolution Medicines, Inc.

RVMD|76155X100

Shares:2.2M

Value:$96.1M

% of Portfolio:45.5% ($96.1M/$210.9M)

Birkenstock Holding plc

BIRK|M2029K104

Shares:1.0M

Value:$57.2M

% of Portfolio:27.1% ($57.2M/$210.9M)

Lineage, Inc.

LINE|53566V106

Shares:600.0K

Value:$35.1M

% of Portfolio:16.7% ($35.1M/$210.9M)

Neumora Therapeutics, Inc.

NMRA|640979100

Shares:2.1M

Value:$22.5M

% of Portfolio:10.7% ($22.5M/$210.9M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Revolution Medicines, Inc.(RVMDcusip76155X100)	2.2M	QoQ- YoY-	All Managers (Combined)	$96.1M	45.5% ($96.1M/$210.9M)	QoQ- YoY-
Birkenstock Holding plc(BIRKcusipM2029K104)	1.0M	QoQ- YoY-	All Managers (Combined)	$57.2M	27.1% ($57.2M/$210.9M)	QoQ- YoY-
Lineage, Inc.(LINEcusip53566V106)	600.0K	QoQ- YoY-	All Managers (Combined)	$35.1M	16.7% ($35.1M/$210.9M)	QoQ- YoY-
Neumora Therapeutics, Inc.(NMRAcusip640979100)	2.1M	QoQ- YoY-	All Managers (Combined)	$22.5M	10.7% ($22.5M/$210.9M)	QoQ- YoY-